Loren Pickart, who first isolated GHK-Cu from human albumin in 1973, has stated: "The tripeptide-copper complex appears to act as a signal that resets gene expression patterns toward a regenerative state, rather than functioning as a simple copper delivery vehicle" [1]
Short cell-penetrating peptides: a model of interactions with gene promoter sites
doi:10.3390/brainsci11111487 McCoy AT, Benoist CC, Wright JW, et al
This human safety record however limited in scope is a meaningful differentiator when researchers evaluate the preclinical-to-translational potential of synthetic peptides
Cycling Protocols for Optimal Results Cycling GHK-Cu helps prevent receptor desensitization, maintains copper homeostasis, and optimizes long-term efficacy
Consequently, you can download the COA before you buy and confirm your compound matches published reference standards